Blood Res 2014; 49(4):
Published online December 31, 2014
https://doi.org/10.5045/br.2014.49.4.211
© The Korean Society of Hematology
1Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
2Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
3Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
#Hee-Jin Kim and Chul Won Choi contributed equally to this work.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Table 1 Major driver gene mutations in
a)
Abbreviations: PV, polycythemia vera; ET, essential thrombocythemia; PMF, primary myelofibrosis; CNL, chronic neutrophilic leukemia; ins/del, insertion/deletion; qPCR, quantitative real-time PCR; AS-PCR, allele-specific PCR.
Table 2 2014 proposed diagnostic criteria for PV, ET, and PMF.
a)PV diagnosis requires meeting either both major criteria and one minor criterion or the first major criterion and two minor criteria.
b)PV diagnosis requires meeting either all three major criteria or the first two major criteria and one minor criterion.
c)ET diagnosis requires meeting all four major criteria.
d)ET diagnosis requires meeting all four major criteria or first three major criteria and one minor criterion.
e)PMF diagnosis requires meeting all three major criteria and two minor criteria.
f)PMF diagnosis requires meeting all three major criteria or the first two major criteria and all three minor criteria.
Abbreviations: BM, bone marrow; EPO, erythropoietin; MK, megakaryocytes
Blood Res 2014; 49(4): 211-213
Published online December 31, 2014 https://doi.org/10.5045/br.2014.49.4.211
Copyright © The Korean Society of Hematology.
Hee-Jin Kim1,#, Chul Won Choi2,#, and Jong-Ho Won3*
1Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
2Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
3Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
#Hee-Jin Kim and Chul Won Choi contributed equally to this work.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Table 1 . Major driver gene mutations in
a)
Abbreviations: PV, polycythemia vera; ET, essential thrombocythemia; PMF, primary myelofibrosis; CNL, chronic neutrophilic leukemia; ins/del, insertion/deletion; qPCR, quantitative real-time PCR; AS-PCR, allele-specific PCR..
Table 2 . 2014 proposed diagnostic criteria for PV, ET, and PMF..
a)PV diagnosis requires meeting either both major criteria and one minor criterion or the first major criterion and two minor criteria..
b)PV diagnosis requires meeting either all three major criteria or the first two major criteria and one minor criterion..
c)ET diagnosis requires meeting all four major criteria..
d)ET diagnosis requires meeting all four major criteria or first three major criteria and one minor criterion..
e)PMF diagnosis requires meeting all three major criteria and two minor criteria..
f)PMF diagnosis requires meeting all three major criteria or the first two major criteria and all three minor criteria..
Abbreviations: BM, bone marrow; EPO, erythropoietin; MK, megakaryocytes.